Orthos licenses bone regeneration technology from Catalonia
8 June 2010
Bristol-based Orthos Limited, which specialises in developing
technologies to help re-grow human bones, has signed an exclusive patent
license agreement with the Biomedical Engineering Research Centre (CREB)
at the University of Catalonia in Spain.
The agreement gives Orthos exclusive rights to the Spanish and
European patents for a self-setting and injectable calcium phosphate
foam which can be used for bone regeneration, enabling them to
exploit the technology commercially.
The agreement was facilitated by Enterprise Europe Network (EEN)
South West. Orthos Limited, which specialises in developing
technologies to help re-grow human bones, contacted EEN to help them
identify opportunities to work with universities across Europe in a
bid to source new technologies.
Alan Rorke, Technical Director at Orthos based at Leigh Court in
Bristol, said, “With the ongoing support of the Enterprise Europe
Network and by collaborating with several major international
universities, including the University of Catalonia, we can continue
to focus on developing the next generation of orthobiologic
The patent agreement gives Orthos exclusive rights to exploit the
university’s technology with CREB benefiting by receiving royalties
on the sale of any Orthos device which uses their technology.
Orthos signed the agreement through EEN’s Partner Alert Service.
This free service helps small and medium-sized companies to identify
European business partners for commercial agreements, technology
partnerships and European research projects.
Kenny Legg, Partnership Adviser at Enterprise Europe Network
South West, said: “Orthos is a prime example of how a company can
benefit from exploiting international academic research. We have
strong links with universities across Europe and strive to increase
collaborative research and development across all sectors by putting
companies and academics in contact with each other.”